tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Bruce Jackson, 142 are a BUY (89.87%), 15 are a HOLD (9.49%), 1 are a SELL (0.63%).
Analyst Bruce Jackson, currently employed at BENCHMARK, carries an average stock price target met ratio of 44.36% that have a potential upside of 31.79% achieved within 169 days.
Bruce Jackson’s has documented 282 price targets and ratings displayed on 27 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HUMA, Humacyte at 21-Jan-2026.
Analyst best performing recommendations are on GNLX (GENELUX COMMON STOCK).
The best stock recommendation documented was for BFRI (BIOFRONTERA) at 12/16/2021. The price target of $220 was fulfilled within 5 days with a profit of $82 (59.42%) receiving and performance score of 118.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 22-Jul-2021
$7.5
4 years 6 months 11 days ago
(22-Jul-2021)
2/2 (100%)
$2.76 (58.23%)
256
Hold Since 03-Dec-2020
$10
$9.54 (2073.91%)
$8
5 years 1 months 30 days ago
(03-Dec-2020)
0/3 (0%)
$2.49 (33.16%)
Buy Since 04-Mar-2020
5 years 7 months 16 days ago
(17-Jun-2020)
2/2 (100%)
$1.27 (34.05%)
162
Buy Since 12-Nov-2019
$12
$11.54 (2508.70%)
5 years 9 months 17 days ago
(16-Apr-2020)
2/2 (100%)
$-0.66 (-5.21%)
83
Which stock is Bruce Jackson is most bullish on?
Which stock is Bruce Jackson is most reserved on?
What Year was the first public recommendation made by Bruce Jackson?
